<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01633294</url>
  </required_header>
  <id_info>
    <org_study_id>335/08 - 28/07/08</org_study_id>
    <nct_id>NCT01633294</nct_id>
  </id_info>
  <brief_title>Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term</brief_title>
  <official_title>Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term - a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Santa Maria, Portugal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Santa Maria, Portugal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of this study are to determine whether antibiotics administered routinely in women
      presenting with premature rupture of membranes later than the 37+0 weeks of gestation can
      alter the rate of maternal and neonatal infection and to compare these rates between prompt
      (&lt; 12 hour) and delayed (≥ 12 hour) induction in the group of patients not submitted to
      antibiotic prophylaxis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>neonatal infection rate</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 3 days</time_frame>
    <description>neonatal infection rate includes early onset sepsis, meningitis and pneumonia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>maternal infection rate</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 3 days</time_frame>
    <description>maternal infection rate includes chorioamnionitis or puerperal endometritis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>comparison of the infection rates between prompt and delayed induction</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 3 days</time_frame>
    <description>rate of maternal and neonatal infection between prompt (&lt;12h) and delayed induction (≥12h) in the group of patients not submitted to antibiotic prophylaxis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">161</enrollment>
  <condition>Chorioamnionitis</condition>
  <condition>Puerperal Endometritis</condition>
  <condition>Neonatal Early Onset Sepsis</condition>
  <condition>Neonatal Meningitis</condition>
  <condition>Neonatal Pneumonia</condition>
  <arm_group>
    <arm_group_label>Antibiotic group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>women submitted to antibiotic prophylaxis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ampicillin + gentamicin</intervention_name>
    <description>ampicillin 1 g every six hours and gentamicin 240 mg every day intravenously</description>
    <arm_group_label>Antibiotic group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  term (≥ 37+0 weeks) singleton pregnancy

          -  a vertex presentation

          -  ruptured membranes for less than 12 hours

          -  negative Group B Streptococcus (GBS) culture performed between 35 and 37 weeks

        Exclusion Criteria:

          -  active labor

          -  absence of GBS culture or indication for GBS antibiotic prophylaxis (such as maternal
             GBS colonization between 35 and 37 weeks, GBS bacteriuria, prior infant with GBS
             sepsis)

          -  contraindication to expectant management (such as fetal distress, meconium staining of
             the amniotic fluid or chorioamnionitis) or to vaginal delivery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Filipa Faria Vaz Passos, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Santa Maria Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Santa Maria</name>
      <address>
        <city>Lisboa</city>
        <zip>1649-035</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2012</study_first_submitted>
  <study_first_submitted_qc>June 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2012</study_first_posted>
  <last_update_submitted>November 24, 2016</last_update_submitted>
  <last_update_submitted_qc>November 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital de Santa Maria, Portugal</investigator_affiliation>
    <investigator_full_name>Filipa Faria Vaz Passos</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>premature rupture of membranes</keyword>
  <keyword>term pregnancy</keyword>
  <keyword>chorioamnionitis</keyword>
  <keyword>endometritis</keyword>
  <keyword>neonatal sepsis</keyword>
  <keyword>antibiotic prophylaxis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Meningitis</mesh_term>
    <mesh_term>Rupture</mesh_term>
    <mesh_term>Endometritis</mesh_term>
    <mesh_term>Chorioamnionitis</mesh_term>
    <mesh_term>Fetal Membranes, Premature Rupture</mesh_term>
    <mesh_term>Neonatal Sepsis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Gentamicins</mesh_term>
    <mesh_term>Ampicillin</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

